Study Stopped
due to COVID-19 and lack of financial means to continue
The Effect of Fish Oils With Dairy or Plant Based Lipids on Mitochondrial and Physical, and Cognitive Function, in Elderly Humans
To Examine the Effect of Dietary Supplementation With Fish Oils With Dairy or Plant Based Lipids on Mitochondrial, Physical, and Cognitive Function, in Elderly Humans
1 other identifier
interventional
25
1 country
2
Brief Summary
The aim of this study is to determine whether dairy or plant based fats combined with fish oils can alter skeletal muscle mitochondrial, physical, and cognitive function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2019
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2019
CompletedFirst Posted
Study publicly available on registry
December 11, 2019
CompletedStudy Start
First participant enrolled
December 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2020
CompletedNovember 13, 2020
November 1, 2020
10 months
December 9, 2019
November 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mitochondrial respiration
Ex vivo mitochondrial respiration expressed by O2flux in pmol/mg wet weight/second
12 weeks
Secondary Outcomes (2)
Physical function
12 weeks
Cognitive Function
12 Weeks
Study Arms (2)
Fish oils and dairy fats
EXPERIMENTALFish oils and plant fats
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Male or/and female;
- Caucasian;
- Age ≥ 65 years;
- BMI ≥ 20 kg/m2 ≤ 30 kg/m2;
- Normal physical activity levels: maximum of 1 hour per week engagement in structured exercise of moderate to high intensity;
- Subject should be in sufficient health to participate in the experiments, to be judged by the site-specific responsible physician, based on the subject's medical history.
You may not qualify if:
- Habitual smoker within the past 5 years;
- Excessive alcohol use (greater than 20g per day) and/or drug abuse;
- Subjects with diagnosed diabetes mellitus type 2;
- Significant food allergies or intolerances concerning the study products, e.g. cow's milk protein allergy
- Participation in another biomedical study possibly interfering with the study results within 1 month before the first study visit;
- Medication use e.g. antithrombotic medications known to hamper subject's safety during the study procedures;
- Subjects habitually taking fish oil supplements within 3-months of the initial study visit or habitually taking supplements that are likely to affect the main study outcomes;
- Subjects who do not want to be informed about unexpected medical findings;
- Subjects who do not want their treating physician to be informed about unexpected medical findings;
- Inability to participate and/or complete the required measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maastricht Universitylead
- Wageningen University and Researchcollaborator
- Netherlands Organisation for Scientific Researchcollaborator
- Top Institute Food and Nutritioncollaborator
Study Sites (2)
Wageningen University and Research
Wageningen, Gelderland, 6700AA, Netherlands
Maastricht University
Maastricht, Limburg, 6200 MD, Netherlands
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Schrauwen, PhD
Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- After subjects have successfully completed the screening, they will be randomly allocated in a 1:1 ratio, using a 4-code system, to one of the two interventions (intervention or control). The intervention and control will each be individually coded with a randomly generated 3 letter coding system with 2 codes allocated to intervention product and the other 2 codes allocated to the control product. sachets will be generated by the product manufacturer and the corresponding blinding label will be added to the sachets, prior to shipment to the study sites. The un-blinding-key will be sent to the project leaders in sealed envelopes. In this way, both the participants and principle investigator will be blinded throughout the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2019
First Posted
December 11, 2019
Study Start
December 11, 2019
Primary Completion
October 15, 2020
Study Completion
October 15, 2020
Last Updated
November 13, 2020
Record last verified: 2020-11